If you love Tales of Arise, the popular JRPG by Bandai Namco will soon get some rather unique merchandise.
The Japanese company Itaindo, which is well-known for this kind of product, will release a set of hanko seals portraying the characters from the game.
If you don’t know what hanko seals are, they’re small wooden stamps that are still in widespread use in Japan, where they serve as signatures. There have been several efforts to phase them out in favor of actual signature, but they’re still rather deeply embedded in Japanese culture.
Further details about the product will be shared at a later date, but for now you can take a look at the teaser image below.
Tales of Arise is currently available for PS5, Xbox Series X|S, PS4, Xbox One, and PC. You can already read our review. The game has already passed 1.5 million copies shipped.
If you’re unfamiliar with the game, you can read an official description below.
“A world of nature drawn with the “Atmospheric Shader”:
We are introducing a new graphics shader, inspired by anime and watercolor painting. Characters with attractive designs travel among backgrounds filled with beautiful and delicate visuals.Explore a world that feels alive:
Explore the world of Dahna, where a mix of unique, natural environments change in appearance based on the time of day. Climb over the rocky terrain, swim in rivers, gather around the campfire, cook food, head to the next town, defeat the master of an alien planet, and liberate the people!Stylish action and battles:
Through the new system “Boost Strike”, you can now chain combos of powerful attacks together with your party members. Chain Artes, Boost Attacks, and Boost Strike combos to take down your enemies!Experience the story of the divided Renan and Dahnan people:
The protagonists who will determine the fate of these two worlds are Alphen and Shionne. They will overcome hardships and grow together with their unique group of friends. Gorgeous animation by ufotable is inserted at key points in the story, adding more color to our protagonists’ journey.”
